Suraj Kalia
Stock Analyst at Oppenheimer
(3.57)
# 896
Out of 4,761 analysts
84
Total ratings
50.72%
Success rate
6.32%
Average return
Main Sectors:
Stocks Rated by Suraj Kalia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VREX Varex Imaging | Maintains: Outperform | $30 → $23 | $12.64 | +81.96% | 6 | Feb 7, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $105 → $120 | $119.44 | +0.47% | 5 | Jan 8, 2025 | |
| TMDX TransMedics Group | Maintains: Outperform | $125 | $71.95 | +73.73% | 9 | Dec 3, 2024 | |
| AORT Artivion | Maintains: Outperform | $30 → $32 | $28.26 | +13.23% | 3 | Nov 8, 2024 | |
| LMAT LeMaitre Vascular | Reiterates: Outperform | $90 → $93 | $99.54 | -6.57% | 2 | Nov 1, 2024 | |
| ATRC AtriCure | Maintains: Outperform | $32 → $36 | $38.39 | -6.23% | 6 | Oct 30, 2024 | |
| ABT Abbott Laboratories | Initiates: Outperform | $130 | $134.92 | -3.65% | 1 | Oct 8, 2024 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $10 | $5.77 | +73.31% | 1 | Sep 16, 2024 | |
| EW Edwards Lifesciences | Maintains: Outperform | $90 | $73.30 | +22.78% | 5 | Sep 12, 2024 | |
| NYXH Nyxoah | Maintains: Outperform | $15 → $13 | $10.35 | +25.64% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $135 | $129.87 | +3.95% | 1 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $231.69 | - | 6 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $5.73 | - | 8 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $30 | $15.05 | +99.34% | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $16 → $10 | $0.35 | +2,754.70% | 1 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $97 | $91.09 | +6.49% | 1 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $26.67 | +4.99% | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $4.5 | $4.30 | +4.65% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $3.54 | +351.98% | 1 | Sep 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $591.79 | - | 3 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $60 | $0.31 | +19,248.60% | 2 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $177.32 | - | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Perform | n/a | $6.30 | - | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $33.82 | +195.68% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $88.78 | - | 5 | Sep 12, 2018 |
Varex Imaging
Feb 7, 2025
Maintains: Outperform
Price Target: $30 → $23
Current: $12.64
Upside: +81.96%
iRhythm Technologies
Jan 8, 2025
Maintains: Outperform
Price Target: $105 → $120
Current: $119.44
Upside: +0.47%
TransMedics Group
Dec 3, 2024
Maintains: Outperform
Price Target: $125
Current: $71.95
Upside: +73.73%
Artivion
Nov 8, 2024
Maintains: Outperform
Price Target: $30 → $32
Current: $28.26
Upside: +13.23%
LeMaitre Vascular
Nov 1, 2024
Reiterates: Outperform
Price Target: $90 → $93
Current: $99.54
Upside: -6.57%
AtriCure
Oct 30, 2024
Maintains: Outperform
Price Target: $32 → $36
Current: $38.39
Upside: -6.23%
Abbott Laboratories
Oct 8, 2024
Initiates: Outperform
Price Target: $130
Current: $134.92
Upside: -3.65%
TriSalus Life Sciences
Sep 16, 2024
Initiates: Outperform
Price Target: $10
Current: $5.77
Upside: +73.31%
Edwards Lifesciences
Sep 12, 2024
Maintains: Outperform
Price Target: $90
Current: $73.30
Upside: +22.78%
Nyxoah
Aug 7, 2024
Maintains: Outperform
Price Target: $15 → $13
Current: $10.35
Upside: +25.64%
Jul 16, 2024
Initiates: Outperform
Price Target: $135
Current: $129.87
Upside: +3.95%
Jun 25, 2024
Downgrades: Perform
Price Target: n/a
Current: $231.69
Upside: -
Feb 22, 2024
Downgrades: Perform
Price Target: n/a
Current: $5.73
Upside: -
Aug 8, 2023
Maintains: Outperform
Price Target: $24 → $30
Current: $15.05
Upside: +99.34%
Jun 23, 2023
Maintains: Outperform
Price Target: $16 → $10
Current: $0.35
Upside: +2,754.70%
May 16, 2023
Initiates: Outperform
Price Target: $97
Current: $91.09
Upside: +6.49%
Mar 6, 2023
Reiterates: Outperform
Price Target: $28
Current: $26.67
Upside: +4.99%
Nov 29, 2022
Initiates: Outperform
Price Target: $4.5
Current: $4.30
Upside: +4.65%
Sep 24, 2021
Initiates: Outperform
Price Target: $16
Current: $3.54
Upside: +351.98%
Apr 21, 2021
Upgrades: Perform
Price Target: n/a
Current: $591.79
Upside: -
Nov 17, 2020
Upgrades: Outperform
Price Target: $60
Current: $0.31
Upside: +19,248.60%
Nov 3, 2020
Upgrades: Perform
Price Target: n/a
Current: $177.32
Upside: -
Sep 15, 2020
Initiates: Perform
Price Target: n/a
Current: $6.30
Upside: -
Jun 24, 2020
Initiates: Outperform
Price Target: $100
Current: $33.82
Upside: +195.68%
Sep 12, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $88.78
Upside: -